Boothbay Fund Management’s GeneDx Holdings WGS Stock Holding History

Boothbay Fund Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Buy	8,722 +1,997	+30%	+$113K	0.01%	1382
2026 Q1	$432K	Buy	6,725 +4,844	+258%	+$442K	0.01%	1423
2025 Q4	$245K	Sell	1,881 -2,534	-57%	-$348K	﹤0.01%	1561
2025 Q3	$476K	Buy	+4,415	New	+$481K	0.01%	1198

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Boothbay Fund Management's WGS Position: Q2 2026 in Review

Boothbay Fund Management increased its GeneDx Holdings (WGS) stake by 30% in Q2 2026, buying an estimated $113K and bringing the position to 8,722 shares worth $599K. The position accounts for 0.01% of the portfolio, ranked #1382.

Boothbay Fund Management first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Boothbay Fund Management held 8,722 shares of GeneDx Holdings worth $599K as of Q2 2026.
Boothbay Fund Management bought 1,997 GeneDx Holdings shares in Q2 2026, an estimated $113K.
GeneDx Holdings made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1382 holding.
Boothbay Fund Management first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.